Novel therapeutics based on tau/microtubule dynamics: WO2008084483

Expert Opinion on Therapeutic Patents

Volumn 19, Issue 9, 2009, Pages 1335-1338

  Alonso, Alejandra Del Carmen ^a   Corbo, Christopher P ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

III tubulin; NAP; Neurodegeneration; Neuroprotective; Tau like peptides

Indexed keywords

HUMANIN; NAP PEPTIDE; PEPTIDE; TAU PROTEIN; TUBULIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; CELL SURVIVAL; DEGENERATIVE DISEASE; DRUG BINDING; DRUG EFFICACY; HUMAN; MICROTUBULE; NEUROPROTECTION; NONHUMAN; REVIEW; TAUOPATHY;

ALZHEIMER DISEASE; ANIMALS; CELL SURVIVAL; HUMANS; MICROTUBULES; NEURODEGENERATIVE DISEASES; PATENTS AS TOPIC; PEPTIDES; PROTEIN BINDING; TAU PROTEINS; TUBULIN;

EID: 69949189957     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543770902887815     Document Type: Review

References (18)

1. Grundke-Iqbal I, Iqbal K, Quinlan M, et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 1986;261(13):6084-6089 (Pubitemid 17207447)
2. Cash AD, Aliev G, Siedlak SL, et al. Raina, Harry V. Vinters, Massimo Tabaton, Anne B. Johnson, Manuel Paula-Barbosa, Jesus Avíla, Paul K. Jones, Rudy J. Castellani, Mark A. Smith and George Perry, microtubule reduction in Alzheimer's disease and aging is independent of filament formation. Am J Pathol 2003;162:1623-1627
3. Anderton BH, Callahan L, Coleman P, et al. Thomas ohm and charles weaver dendritic changes in Alzheimer's disease and factors that may underlie these changes. Prog Neurobiol 1998;55(6):595-609
4. Scheff SW, Price DA, Schmitt FA, et al. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007;68:1501-1508 (Pubitemid 46685921)
5. Jack CR Jr, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008;55:1-16
6. Alonso A del C, Grundke lqbal I, Iqbal K. Hyperphosphorylated tau from Alzheimer disease brain disassembles microtubules and sequesters normal tau into tangles filaments. Nature Med 1996;2:783-787
7. Alonso A del C, Zaidi T, Novak M, et al. Hyperphosphorylation induces self - assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 2001;98:6923-6928 (Pubitemid 32538318)
8. Patočka J, Slaninová J, Kunešová G. Neuroprotective peptides as drug candidates against Alzheimer's diasease. J Appl Biomed 2005;3:67-73 (Pubitemid 41529381)
9. Krejčová G, Patočka J, Slaninová J. Effect of humanin analogues on experimentally induced impairment of spatial memory in rats. J Pept Sci 2004;10:636-639 (Pubitemid 39409623)
10. Mamiya T, Ukai M. [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 2001;134:1597-1599 (Pubitemid 34038091)
11. Gozes I, Divinski I. NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell. Curr Alzheimer Res 2007;4(5):507-509 (Pubitemid 350248382)
12. Bhattacharya R, Cabral F. A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation. Mol Biol Cell 2004;15(7):3123-3131 (Pubitemid 38850110)
13. Argaraña CE, Arce CA, Barra HS, Caputto R. In vivo incorporation of [14C] tyrosine into the C-terminal position of the alpha subunit of tubulin. Arch Biochem Biophys 1977;180(2):264-268
14. Jehle T, Dimitriu C, Auer S, et al. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Graefes Arch Clin Exp Ophthalmol 2008;246(9):1255-63. Erratum in: Graefes Arch Clin Exp Ophthalmol 2008;246(9):1355. [Epub 15 Apr 2008]
15. Matsuoka Y, Jouroukhin Y, Gray AJ, et al. A neuronal microtubule- interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther 2008;325(1):146-153
16. Vulih-Shultzman I, Pinhasov A, Mandel S, et al. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J Pharmacol Exp Ther 2007;323(2):438-449 (Pubitemid 350005131)
17. Matsuoka Y, Gray AJ, Hirata-Fukae C, et al. Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage. J Mol Neurosci 2007;31(2):165-170 (Pubitemid 46742300)
18. Laurén J, Gimbel DA, Nygaard HB, et al. Cellular prion protein mediates impairment of synaptic plasticity by amyloid- oligomers. Nature 2009;457:1128-1132